Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ENZN |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Enzon Pharmaceuticals Inc | 7.0M | 71.6x | -60.21% |
Alzamend Neuro Inc | 7.0M | -0.4x | --- |
ENDRA Life Sciences Inc | 6.9M | -0.2x | --- |
Creative Medical Technology Holdings Inc | 7.0M | -1.4x | --- |
GlucoTrack Inc | 7.0M | -1.0x | --- |
Cell MedX Corp | 7.1M | -4.5x | --- |
Enzon Pharmaceuticals, Inc. (Enzon) is an acquisition vehicle company. The Company intends to become an acquisition platform. The Company utilizes its net operating loss carryforwards (NOLs) and improves stockholder value. It manages its source of royalty revenues from existing licensing arrangements with other companies.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.0M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 74.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.30 |
EPS | $0.00 |
Book Value | $0.62 |
P/E Ratio | 71.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.